Suppr超能文献

门诊主动脉瓣狭窄严重程度与死亡率的相关性:VALVENOR 研究结果。

Association of Mortality With Aortic Stenosis Severity in Outpatients: Results From the VALVENOR Study.

机构信息

University Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, Lille, France.

University of Liège Hospital, GIGA Cardiovascular Sciences, Department of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium.

出版信息

JAMA Cardiol. 2021 Dec 1;6(12):1424-1431. doi: 10.1001/jamacardio.2021.3718.

Abstract

IMPORTANCE

Modern data regarding incidence and modes of death of patients with aortic stenosis (AS) are restricted to tertiary centers or studies of aortic valve replacement (AVR).

OBJECTIVE

To provide new insights into the natural history of outpatients with native AS based on a large regionwide population study with inclusion by all cardiologists regardless of their mode of practice.

DESIGN, SETTING, AND PARTICIPANTS: Between May 2016 and December 2017, consecutive outpatients with mild (peak aortic velocity, 2.5-2.9 m/s), moderate (peak aortic velocity, 3-3.9 m/s), and severe (peak aortic velocity, ≥4 m/s) native AS graded by echocardiography were included by 117 cardiologists from the Nord-Pas-de-Calais region in France. Analysis took place between August and November 2020.

MAIN OUTCOMES AND MEASURES

Natural history, need for AVR, and survival of patients with AS were followed up. Indications for AVR were based on current guideline recommendations.

RESULTS

Among 2703 patients (mean [SD] age, 76.0 [10.8] years; 1260 [46.6%] women), 233 (8.6%) were recruited in a university public hospital, 757 (28%) in nonuniversity public hospitals, and 1713 (63.4%) by cardiologists working in private practice. A total of 1154 patients (42.7%) had mild, 1122 (41.5%) had moderate, and 427 (15.8%) had severe AS. During a median (interquartile range) of 2.1 (1.4-2.7) years, 634 patients underwent AVR and 448 died prior to AVR. Most deaths were cardiovascular (200 [44.7%]), mainly associated with congestive heart failure (101 [22.6%]) or sudden death (60 [13.4%]). Deaths were noncardiovascular in 186 patients (41.5%) and from unknown causes in 62 patients (13.8%). Compared with patients with mild AS, there was increased cardiovascular mortality in those with moderate (hazard ratio, 1.47 [95% CI, 1.07-2.02]) and severe (hazard ratio, 3.66 [95% CI, 2.52-5.31]) AS. The differences remained significant when adjusted for baseline characteristics or in time-dependent analyses considering AS progression. In asymptomatic patients, moderate and mild AS were associated with similar cardiovascular mortality (hazard ratio, 0.99 [95% CI, 0.44-2.21]).

CONCLUSIONS AND RELEVANCE

While patients in this study with moderate AS had a slightly higher risk of cardiovascular death than patients with mild AS, this risk was much lower than that observed in patients with severe AS. Moreover, in asymptomatic patients, moderate and mild AS were associated with similar cardiovascular mortality.

摘要

重要性

关于主动脉瓣狭窄(AS)患者的发病率和死亡模式的现代数据仅限于三级中心或主动脉瓣置换(AVR)的研究。

目的

通过一项基于大区范围人群研究的大型研究,纳入所有心脏病专家,无论其执业模式如何,为接受原发性 AS 治疗的门诊患者的自然病史提供新的见解。

设计、地点和参与者:2016 年 5 月至 2017 年 12 月,法国北部-加来海峡地区的 117 位心脏病专家连续纳入经超声心动图诊断为轻度(峰值主动脉速度,2.5-2.9m/s)、中度(峰值主动脉速度,3-3.9m/s)和重度(峰值主动脉速度,≥4m/s)的原发性 AS 的连续门诊患者。分析于 2020 年 8 月至 11 月进行。

主要结果和措施

对 AS 患者的自然病史、AVR 需求和生存情况进行随访。AVR 的适应证基于当前指南建议。

结果

在 2703 名患者(平均[标准差]年龄 76.0[10.8]岁;1260[46.6%]为女性)中,233 名(8.6%)在大学公立医院就诊,757 名(28%)在非大学公立医院就诊,1713 名(63.4%)由在私人诊所工作的心脏病专家收治。共有 1154 名(42.7%)患者患有轻度 AS,1122 名(41.5%)患者患有中度 AS,427 名(15.8%)患者患有重度 AS。在中位(四分位距)2.1(1.4-2.7)年期间,634 名患者接受了 AVR,448 名患者在 AVR 前死亡。大多数死亡是心血管性的(200 例[44.7%]),主要与充血性心力衰竭(101 例[22.6%])或猝死(60 例[13.4%])有关。186 例(41.5%)患者死于非心血管性疾病,62 例(13.8%)患者死因不明。与轻度 AS 患者相比,中度(风险比,1.47[95%CI,1.07-2.02])和重度(风险比,3.66[95%CI,2.52-5.31])AS 患者的心血管死亡率增加。在调整基线特征或考虑 AS 进展的时间依赖性分析后,差异仍然显著。在无症状患者中,中度和轻度 AS 与相似的心血管死亡率相关(风险比,0.99[95%CI,0.44-2.21])。

结论和相关性

虽然该研究中的中度 AS 患者的心血管死亡风险略高于轻度 AS 患者,但远低于重度 AS 患者。此外,在无症状患者中,中度和轻度 AS 与相似的心血管死亡率相关。

相似文献

引用本文的文献

7
Harnessing Artificial Intelligence for Innovation in Interventional Cardiovascular Care.利用人工智能推动介入性心血管护理创新。
J Soc Cardiovasc Angiogr Interv. 2025 Mar 18;4(3Part B):102562. doi: 10.1016/j.jscai.2025.102562. eCollection 2025 Mar.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验